- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Earnings Season kick-off: Alcoa CEO Klaus Kleinfeld on expansion plans in China.
A-Power Energy joins the China stock trend. First, its auditor resigns then the exchange halts trading of company's shares.
Carl Icahn amasses a 9.5% stake in truckmaker Oshkosh
More regulatory scrutiny, this time from the SEC, descends on the controversial seed producer Monsanto.
Monsanto boss Hugh Grant trumpets a turnaround with the company's latest third-quarter results.
NEW YORK (TheStreet) -- Reporter Scot Eden explains the allegations against China-Biotics, why its auditor just resigned and what happens now.
The auditor of another Chinese reverse-merger company claims to have found evidence of an elaborate ruse to defraud investors.
Hear are some of the major headlines that have moved China small-cap stocks so far in 2011.
As the China-stock fraud scandal continues to widen, bulge-bracket banks and blue-chip fund managers are getting swept along for the ride.
Matthew Wiechert used to work on the China-stock buy side. But he's had a change of heart, he tells TheStreet's Scott Eden, and has gone to the short side.